Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NEJM Study Supports CT Colonography As Primary Colon Cancer Screen

This article was originally published in The Gray Sheet

Executive Summary

Computed tomography imaging colonography may be a better method for primary colorectal cancer screening than optical colonoscopy, according to the authors of a study published Oct. 4 in the New England Journal of Medicine

You may also be interested in...



CT Colonoscopy Gets Further Support From NCI Study In NEJM

Results of a major study sponsored by the National Cancer Institute and the American College of Radiology Imaging Network provide more support for computed tomographic colonography as an alternative to visual colonoscopy for colorectal cancer screening

CT Colonoscopy Gets Further Support From NCI Study In NEJM

Results of a major study sponsored by the National Cancer Institute and the American College of Radiology Imaging Network provide more support for computed tomographic colonography as an alternative to visual colonoscopy for colorectal cancer screening

Virtual Colonoscopy Catches CMS Eye; National Coverage Being Considered

The Medicare agency said May 19 it will consider providing national coverage for computed tomography colonography for cancer screening, a new technology that has gained visibility in recent months

Latest Headlines
See All
UsernamePublicRestriction

Register

MT025344

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel